Medilink West Midlands are pleased to announce that MasterControl have signed up as the Headline Sponsor for Medilink WM Medical and Healthcare Business Awards 2018.
The Awards ceremony, which has been running for over 10 years, celebrates the best in life sciences and medical technology across the West Midlands region and will be taking place this year on the 7th February at the Birmingham Conference and Events Centre. As well as announcing our 2018 winners, the event will also provide delegates with an evening of great entertainment and networking opportunities, making it the biggest event within the Medilink West Midlands calendar.
Stephen Turnock, Sales Director EMEA at MasterControl, said: “We’re delighted to support the 2018 Medical and Healthcare Business Awards 2018 and to be part of an event which celebrates innovation and highlights the amazing work being done across the West Midlands’ medical technology and life sciences sectors.
We are really looking forward to celebrating with the winners this year.”
MasterControl provides a full line of industry‐specific quality and compliance software solutions and services for organisations of all sizes. Their integrated solution allows companies to track and manage all of the individual quality processes that are critical to regulated companies in one seamless environment, enabling accelerated compliance and faster market delivery.
We would like to say a huge thank you to all of our sponsors this year for their continued support, including our headline sponsor MasterControl; Calthorpe Estates, our Start Up Award sponsor; Medilink WM patron Marks & Clerk, our sponsor for this year’s Innovation Award; West Midlands Academic Health Science Network (WMAHSN), our Partnership with the NHS Award sponsor; and Medilink Midlands, our Outstanding Achievement Award sponsor.
Tickets for the event are still available and you can register your place here.
For more information and to keep up to date with our latest Awards news, follow @MedilinkWM and the hashtag #MWMAwards18 on Twitter.